T2	Participants 227 250	high-risk breast cancer
T1	Participants 79 102	high-risk breast cancer
T3	Participants 300 337	patients with high-risk breast cancer
T4	Participants 1556 1574	high-risk patients
T5	Participants 1815 1838	high-risk breast cancer
